BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 22529961)

  • 1. Myosin light chain kinase mediates intestinal barrier disruption following burn injury.
    Chen C; Wang P; Su Q; Wang S; Wang F
    PLoS One; 2012; 7(4):e34946. PubMed ID: 22529961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p38 MAPK in burn-induced intestinal barrier breakdown.
    Costantini TW; Peterson CY; Kroll L; Loomis WH; Eliceiri BP; Baird A; Bansal V; Coimbra R
    J Surg Res; 2009 Sep; 156(1):64-9. PubMed ID: 19577248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine protects against burn-induced intestinal barrier injury via the MLCK/p-MLC signalling pathway.
    Qin C; Jiang Y; Chen X; Bian Y; Wang Y; Xie K; Yu Y
    Burns; 2021 Nov; 47(7):1576-1585. PubMed ID: 33933302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury.
    Guo M; Yuan SY; Frederich BJ; Sun C; Shen Q; McLean DL; Wu MH
    Shock; 2012 Oct; 38(4):436-43. PubMed ID: 22814287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model.
    Luo HM; Du MH; Lin ZL; Zhang L; Ma L; Wang H; Yu W; Lv Y; Lu JY; Pi YL; Hu S; Sheng ZY
    PLoS One; 2013; 8(10):e77523. PubMed ID: 24147016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
    Lapointe TK; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
    Ye X; Sun M
    Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
    Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
    Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
    Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
    Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase.
    Costantini TW; Loomis WH; Putnam JG; Kroll L; Eliceiri BP; Baird A; Bansal V; Coimbra R
    J Trauma; 2009 Jan; 66(1):17-24; discussion 24-5. PubMed ID: 19131801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on intestinal tight junction barrier dysfunction should be emphasized in burn injury].
    Wang FJ
    Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):331-3. PubMed ID: 21162780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.
    Schwarz BT; Wang F; Shen L; Clayburgh DR; Su L; Wang Y; Fu YX; Turner JR
    Gastroenterology; 2007 Jun; 132(7):2383-94. PubMed ID: 17570213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion.
    Scott KG; Meddings JB; Kirk DR; Lees-Miller SP; Buret AG
    Gastroenterology; 2002 Oct; 123(4):1179-90. PubMed ID: 12360480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.